Compare DexCom, Inc. (DXCM) vs Tidewater Inc (TDW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
DexCom, Inc. vs Tidewater Inc — how do they compare? DexCom, Inc. trades at $77.03 (market cap $28.06B), while Tidewater Inc trades at $74.93 (market cap $3.72B). The key difference: DexCom, Inc. is far larger — about 7.5× Tidewater Inc's market cap. Which is the better fit depends on your goals.
| DXCM | TDW | |
|---|---|---|
Market Cap | $28.06B | $3.72B |
Sector | Health | Utilities |
52-Week High | $89.53 | $91.12 |
52-Week Low | $54.84 | $46.32 |
Enterprise Value | $27.03B | $3.83B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
DXCM trades at $77.31, up 4.3% on the day, with a bullish technical outlook as it approaches resistance near $78. The company reported strong earnings beats in recent quarters, with Q1 2026 EPS of $0.56 surpassing expectations of $0.47. Revenue growth accelerated to $4.66 billion in 2025, while net income margin expanded to 17.93%. Recent regulatory approvals, including Health Canada authorization for the G7 15-day CGM, support continued international expansion.
The stock offers growth potential with analyst consensus price target of $84.33, though high valuation multiples (P/E 31.21) and competition in the CGM market present risks. Expansion into non-insulin Type 2 diabetes and pediatric markets could drive future revenue, but commercial uptake remains unproven. Institutional sentiment remains strongly bullish with 80% buy ratings.
Tidewater (TDW) trades at $75.90, up 2.61% with a bullish technical signal despite recent earnings misses. The company maintains strong profitability with 22.16% net margins and 24.03% ROE, though Q1 2026 earnings of $0.12 missed expectations. Recent news includes FTAI Infrastructure's acquisition of Tidewater Logistics, potentially restructuring operations. Valuation appears reasonable with P/E of 12.63 and EV/EBITDA of 9.33.
Outlook remains mixed with analyst consensus leaning hold (61.54%) amid earnings volatility. The stock offers value fundamentals but faces execution risks after recent misses. Key catalysts include Q2 2026 earnings and integration of recent acquisitions, while risks include energy sector volatility and competitive pressures in offshore services.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About DexCom, Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetics. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to include the disposable sensor and the durable receiver.
Read more on DXCM →About Tidewater Inc
Tidewater is the leading global provider of offshore support vessels (OSVs) to the energy industry. With the world's largest fleet of platform supply vessels (PSVs) and anchor handling tugs (AHTS), it provides critical logistics and marine support for offshore oil, gas, and renewable energy projects. Following a period of massive strategic consolidation, Tidewater is now focused on maximizing day rates and free cash flow in a supply-constrained market, positioning itself as a primary beneficiary of the multi-year offshore upcycle.
Read more on TDW →
